352 related articles for article (PubMed ID: 29309771)
1. The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients.
Ponti G; Maccaferri M; Manfredini M; Kaleci S; Mandrioli M; Pellacani G; Ozben T; Depenni R; Bianchi G; Pirola GM; Tomasi A
Clin Chim Acta; 2018 Apr; 479():14-19. PubMed ID: 29309771
[TBL] [Abstract][Full Text] [Related]
2. Comparison of UV spectrometry and fluorometry-based methods for quantification of cell-free DNA in red cell components.
Khetan D; Gupta N; Chaudhary R; Shukla JS
Asian J Transfus Sci; 2019; 13(2):95-99. PubMed ID: 31896914
[TBL] [Abstract][Full Text] [Related]
3. Pitfalls of DNA Quantification Using DNA-Binding Fluorescent Dyes and Suggested Solutions.
Nakayama Y; Yamaguchi H; Einaga N; Esumi M
PLoS One; 2016; 11(3):e0150528. PubMed ID: 26937682
[TBL] [Abstract][Full Text] [Related]
4. The predictive and prognostic significance of cell-free DNA concentration in melanoma.
Váraljai R; Elouali S; Lueong SS; Wistuba-Hamprecht K; Seremet T; Siveke JT; Becker JC; Sucker A; Paschen A; Horn PA; Neyns B; Weide B; Schadendorf D; Roesch A
J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):387-395. PubMed ID: 32569440
[TBL] [Abstract][Full Text] [Related]
5. Study on the admission levels of circulating cell-free DNA in patients with acute myocardial infarction using different quantification methods.
Agiannitopoulos K; Samara P; Papadopoulou E; Tsamis K; Mertzanos G; Babalis D; Lamnissou K
Scand J Clin Lab Invest; 2020 Jul; 80(4):348-350. PubMed ID: 32077765
[TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy with cell free DNA: new horizons for prostate cancer.
Ponti G; Maccaferri M; Percesepe A; Tomasi A; Ozben T
Crit Rev Clin Lab Sci; 2021 Jan; 58(1):60-76. PubMed ID: 32805148
[TBL] [Abstract][Full Text] [Related]
7. Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.
Chen E; Cario CL; Leong L; Lopez K; Márquez CP; Chu C; Li PS; Oropeza E; Tenggara I; Cowan J; Simko JP; Chan JM; Friedlander T; Wyatt AW; Aggarwal R; Paris PL; Carroll PR; Feng F; Witte JS
Sci Rep; 2021 Mar; 11(1):5040. PubMed ID: 33658587
[TBL] [Abstract][Full Text] [Related]
8. Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis.
Ponti G; Maccaferri M; Manfredini M; Micali S; Torricelli F; Milandri R; Del Prete C; Ciarrocchi A; Ruini C; Benassi L; Bettelli S; Kaleci S; Ozben T; Tomasi A
Clin Chim Acta; 2019 Oct; 497():76-80. PubMed ID: 31301282
[TBL] [Abstract][Full Text] [Related]
9. Seminal Cell Free DNA Concentration Levels Discriminate Between Prostate Cancer and Benign Prostatic Hyperplasia.
Ponti G; Maccaferri M; Micali S; Manfredini M; Milandri R; Bianchi G; Pellacani G; Kaleci S; Chester J; Conti A; Del Prete C; Tomasi A
Anticancer Res; 2018 Sep; 38(9):5121-5125. PubMed ID: 30194158
[TBL] [Abstract][Full Text] [Related]
10. DNA qualification workflow for next generation sequencing of histopathological samples.
Simbolo M; Gottardi M; Corbo V; Fassan M; Mafficini A; Malpeli G; Lawlor RT; Scarpa A
PLoS One; 2013; 8(6):e62692. PubMed ID: 23762227
[TBL] [Abstract][Full Text] [Related]
11. Feasibility Analysis of Cell-Free DNA Derived from Plasma of Lung Cancer Patients for Next-Generation Sequencing.
Jiang X; Li H; Liu J; Sun H; Zhang L; Li W; Yao J; Cheng Y
Biopreserv Biobank; 2020 Apr; 18(2):117-121. PubMed ID: 32083487
[No Abstract] [Full Text] [Related]
12. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients.
Valpione S; Gremel G; Mundra P; Middlehurst P; Galvani E; Girotti MR; Lee RJ; Garner G; Dhomen N; Lorigan PC; Marais R
Eur J Cancer; 2018 Jan; 88():1-9. PubMed ID: 29175734
[TBL] [Abstract][Full Text] [Related]
13. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
[TBL] [Abstract][Full Text] [Related]
14. Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker.
Ponti G; Maccaferri M; Mandrioli M; Manfredini M; Micali S; Cotugno M; Bianchi G; Ozben T; Pellacani G; Del Prete C; Tomasi A
Pathol Oncol Res; 2018 Oct; 24(4):941-945. PubMed ID: 29730802
[TBL] [Abstract][Full Text] [Related]
15. Cell-free circulating tumor DNA in colorectal cancer: a proof of concept with simplified methodology.
Bosque J; Guirao C; Ferrández A; Suarez N; Castillejo MI; Anguita D; Pamies M; Moya A; Soto JL; Gallego Plazas J
Clin Transl Oncol; 2022 Oct; 24(10):1924-1931. PubMed ID: 35499600
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Cell-Free DNA (cfDNA) in Muscle-Invasive Bladder Cancer Treatment Outcome.
Papadimitriou MA; Levis P; Kotronopoulos G; Stravodimos K; Avgeris M; Scorilas A
Clin Chem; 2023 Apr; 69(4):399-410. PubMed ID: 36738246
[TBL] [Abstract][Full Text] [Related]
17. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
Ponti G; Manfredini M; Tomasi A
Crit Rev Oncol Hematol; 2019 Sep; 141():36-42. PubMed ID: 31212145
[TBL] [Abstract][Full Text] [Related]
18. Circulating cell-free DNA does not harbour a diagnostic benefit in cats with feline diffuse iris melanomas.
Rushton JG; Ertl R; Klein D; Tichy A; Nell B
J Feline Med Surg; 2019 Feb; 21(2):124-132. PubMed ID: 29529957
[TBL] [Abstract][Full Text] [Related]
19. Comparative assessment of DNA extraction procedures for
Amoah ID; Singh G; Troell K; Reddy P; Stenström TA; Bux F
J Helminthol; 2019 Aug; 94():e78. PubMed ID: 31455433
[TBL] [Abstract][Full Text] [Related]
20. Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of
Kloten V; Rüchel N; Brüchle NO; Gasthaus J; Freudenmacher N; Steib F; Mijnes J; Eschenbruch J; Binnebösel M; Knüchel R; Dahl E
Oncotarget; 2017 Oct; 8(49):86253-86263. PubMed ID: 29156792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
